ID   EPHA5_HUMAN             Reviewed;        1037 AA.
AC   P54756; Q7Z3F2;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   22-SEP-2009, sequence version 3.
DT   10-MAY-2017, entry version 176.
DE   RecName: Full=Ephrin type-A receptor 5;
DE            EC=2.7.10.1;
DE   AltName: Full=Brain-specific kinase;
DE   AltName: Full=EPH homology kinase 1;
DE            Short=EHK-1;
DE   AltName: Full=EPH-like kinase 7;
DE            Short=EK7;
DE            Short=hEK7;
DE   Flags: Precursor;
GN   Name=EPHA5; Synonyms=BSK, EHK1, HEK7, TYRO4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=9191074; DOI=10.1016/S0169-328X(96)00268-9;
RA   Miescher G.C., Taylor V., Olivieri G., Mindermann T., Shrock E.,
RA   Steck A.J.;
RT   "Extensive splice variation and localization of the EHK-1 receptor
RT   tyrosine kinase in adult human brain and glial tumors.";
RL   Brain Res. Mol. Brain Res. 46:17-24(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Retina;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 25-1037.
RC   TISSUE=Brain;
RX   PubMed=7898931;
RA   Fox G.M., Holst P.L., Chute H.T., Lindberg R.A., Janssen A.M.,
RA   Basu R., Welcher A.A.;
RT   "cDNA cloning and tissue distribution of five human EPH-like receptor
RT   protein-tyrosine kinases.";
RL   Oncogene 10:897-905(1995).
RN   [5]
RP   IDENTIFICATION OF EFNA5 AS LIGAND, AND PHOSPHORYLATION.
RX   PubMed=7748564; DOI=10.1016/0896-6273(95)90335-6;
RA   Winslow J.W., Moran P., Valverde J., Shih A., Yuan J.Q., Wong S.C.,
RA   Tsai S.P., Goddard A., Henzel W.J., Hefti F., Beck K.D., Caras I.W.;
RT   "Cloning of AL-1, a ligand for an Eph-related tyrosine kinase receptor
RT   involved in axon bundle formation.";
RL   Neuron 14:973-981(1995).
RN   [6]
RP   NOMENCLATURE.
RX   PubMed=9267020;
RG   Eph nomenclature committee;
RT   "Unified nomenclature for Eph family receptors and their ligands, the
RT   ephrins.";
RL   Cell 90:403-404(1997).
RN   [7]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=10375373; DOI=10.1177/002215549904700702;
RA   Olivieri G., Miescher G.C.;
RT   "Immunohistochemical localization of EphA5 in the adult human central
RT   nervous system.";
RL   J. Histochem. Cytochem. 47:855-861(1999).
RN   [8]
RP   VARIANTS [LARGE SCALE ANALYSIS] THR-81; ALA-235; GLN-330; GLN-417;
RP   LYS-503; CYS-506; GLU-582; THR-672; THR-673; ILE-856; ARG-959 AND
RP   SER-1032.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Receptor tyrosine kinase which binds promiscuously GPI-
CC       anchored ephrin-A family ligands residing on adjacent cells,
CC       leading to contact-dependent bidirectional signaling into
CC       neighboring cells. The signaling pathway downstream of the
CC       receptor is referred to as forward signaling while the signaling
CC       pathway downstream of the ephrin ligand is referred to as reverse
CC       signaling. Among GPI-anchored ephrin-A ligands, EFNA5 most
CC       probably constitutes the cognate/functional ligand for EPHA5.
CC       Functions as an axon guidance molecule during development and may
CC       be involved in the development of the retinotectal, entorhino-
CC       hippocampal and hippocamposeptal pathways. Together with EFNA5
CC       plays also a role in synaptic plasticity in adult brain through
CC       regulation of synaptogenesis. In addition to its function in the
CC       nervous system, the interaction of EPHA5 with EFNA5 mediates
CC       communication between pancreatic islet cells to regulate glucose-
CC       stimulated insulin secretion (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate. {ECO:0000255|PROSITE-
CC       ProRule:PRU10028}.
CC   -!- SUBUNIT: Heterotetramer upon binding of the ligand. The
CC       heterotetramer is composed of an ephrin dimer and a receptor
CC       dimer. Oligomerization is probably required to induce biological
CC       responses (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000250|UniProtKB:P54757}; Single-pass type I membrane
CC       protein {ECO:0000255}. Cell projection, axon
CC       {ECO:0000250|UniProtKB:P54757}. Cell projection, dendrite
CC       {ECO:0000250|UniProtKB:P54756}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=P54756-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P54756-2; Sequence=VSP_002999;
CC       Name=3;
CC         IsoId=P54756-3; Sequence=VSP_039118, VSP_039119;
CC   -!- TISSUE SPECIFICITY: Almost exclusively expressed in the nervous
CC       system in cortical neurons, cerebellar Purkinje cells and
CC       pyramidal neurons within the cortex and hippocampus. Display an
CC       increasing gradient of expression from the forebrain to hindbrain
CC       and spinal cord. {ECO:0000269|PubMed:10375373,
CC       ECO:0000269|PubMed:9191074}.
CC   -!- PTM: Phosphorylated. Phosphorylation is stimulated by the ligand
CC       EFNA5. Dephosphorylation upon stimulation by glucose, inhibits
CC       EPHA5 forward signaling and results in insulin secretion (By
CC       similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. Ephrin receptor subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X95425; CAA64700.1; -; mRNA.
DR   EMBL; AC018683; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC104137; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC105923; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC115223; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BX537946; CAD97914.1; -; mRNA.
DR   EMBL; L36644; AAA74245.1; -; mRNA.
DR   CCDS; CCDS3513.1; -. [P54756-1]
DR   CCDS; CCDS3514.1; -. [P54756-2]
DR   RefSeq; NP_001268694.1; NM_001281765.2.
DR   RefSeq; NP_001268695.1; NM_001281766.2.
DR   RefSeq; NP_001305690.1; NM_001318761.1. [P54756-3]
DR   RefSeq; NP_004430.4; NM_004439.7. [P54756-1]
DR   RefSeq; NP_872272.2; NM_182472.4. [P54756-2]
DR   UniGene; Hs.654492; -.
DR   PDB; 2R2P; X-ray; 2.40 A; A=653-939.
DR   PDB; 4ET7; X-ray; 2.60 A; A=59-235.
DR   PDBsum; 2R2P; -.
DR   PDBsum; 4ET7; -.
DR   ProteinModelPortal; P54756; -.
DR   SMR; P54756; -.
DR   BioGrid; 108358; 4.
DR   IntAct; P54756; 2.
DR   MINT; MINT-4722838; -.
DR   STRING; 9606.ENSP00000273854; -.
DR   BindingDB; P54756; -.
DR   ChEMBL; CHEMBL3987; -.
DR   GuidetoPHARMACOLOGY; 1825; -.
DR   iPTMnet; P54756; -.
DR   PhosphoSitePlus; P54756; -.
DR   BioMuta; EPHA5; -.
DR   DMDM; 259016353; -.
DR   EPD; P54756; -.
DR   MaxQB; P54756; -.
DR   PaxDb; P54756; -.
DR   PeptideAtlas; P54756; -.
DR   PRIDE; P54756; -.
DR   TopDownProteomics; P54756-2; -. [P54756-2]
DR   Ensembl; ENST00000273854; ENSP00000273854; ENSG00000145242. [P54756-1]
DR   Ensembl; ENST00000354839; ENSP00000346899; ENSG00000145242. [P54756-2]
DR   GeneID; 2044; -.
DR   KEGG; hsa:2044; -.
DR   UCSC; uc003hcy.5; human. [P54756-1]
DR   CTD; 2044; -.
DR   DisGeNET; 2044; -.
DR   GeneCards; EPHA5; -.
DR   HGNC; HGNC:3389; EPHA5.
DR   MIM; 600004; gene.
DR   neXtProt; NX_P54756; -.
DR   OpenTargets; ENSG00000145242; -.
DR   PharmGKB; PA27821; -.
DR   eggNOG; KOG0196; Eukaryota.
DR   eggNOG; COG0515; LUCA.
DR   GeneTree; ENSGT00760000118975; -.
DR   HOVERGEN; HBG062180; -.
DR   InParanoid; P54756; -.
DR   KO; K05106; -.
DR   PhylomeDB; P54756; -.
DR   TreeFam; TF315608; -.
DR   BRENDA; 2.7.10.1; 2681.
DR   Reactome; R-HSA-2682334; EPH-Ephrin signaling.
DR   Reactome; R-HSA-3928663; EPHA-mediated growth cone collapse.
DR   Reactome; R-HSA-3928665; EPH-ephrin mediated repulsion of cells.
DR   SignaLink; P54756; -.
DR   SIGNOR; P54756; -.
DR   ChiTaRS; EPHA5; human.
DR   EvolutionaryTrace; P54756; -.
DR   GeneWiki; EPH_receptor_A5; -.
DR   GenomeRNAi; 2044; -.
DR   PRO; PR:P54756; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000145242; -.
DR   CleanEx; HS_EPHA5; -.
DR   ExpressionAtlas; P54756; baseline and differential.
DR   Genevisible; P54756; HS.
DR   GO; GO:0030424; C:axon; IEA:UniProtKB-SubCell.
DR   GO; GO:0030425; C:dendrite; IDA:UniProtKB.
DR   GO; GO:0009897; C:external side of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IEA:InterPro.
DR   GO; GO:0043025; C:neuronal cell body; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005791; C:rough endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005003; F:ephrin receptor activity; ISS:UniProtKB.
DR   GO; GO:0005004; F:GPI-linked ephrin receptor activity; ISS:UniProtKB.
DR   GO; GO:0005005; F:transmembrane-ephrin receptor activity; NAS:UniProtKB.
DR   GO; GO:0007411; P:axon guidance; ISS:UniProtKB.
DR   GO; GO:0019933; P:cAMP-mediated signaling; ISS:UniProtKB.
DR   GO; GO:0048013; P:ephrin receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0021766; P:hippocampus development; ISS:UniProtKB.
DR   GO; GO:0048666; P:neuron development; IEP:UniProtKB.
DR   GO; GO:0032793; P:positive regulation of CREB transcription factor activity; ISS:UniProtKB.
DR   GO; GO:0032956; P:regulation of actin cytoskeleton organization; ISS:UniProtKB.
DR   GO; GO:0043087; P:regulation of GTPase activity; ISS:UniProtKB.
DR   GO; GO:0061178; P:regulation of insulin secretion involved in cellular response to glucose stimulus; ISS:UniProtKB.
DR   CDD; cd10483; EphR_LBD_A5; 1.
DR   CDD; cd00063; FN3; 2.
DR   Gene3D; 2.60.120.260; -; 1.
DR   Gene3D; 2.60.40.10; -; 2.
DR   InterPro; IPR027936; Eph_TM.
DR   InterPro; IPR034277; EphA5_rcpt_lig-bd.
DR   InterPro; IPR001090; Ephrin_rcpt_lig-bd_dom.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR008979; Galactose-bd-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR013761; SAM/pointed.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR011641; Tyr-kin_ephrin_A/B_rcpt-like.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR016257; Tyr_kinase_ephrin_rcpt.
DR   InterPro; IPR001426; Tyr_kinase_rcpt_V_CS.
DR   Pfam; PF14575; EphA2_TM; 1.
DR   Pfam; PF01404; Ephrin_lbd; 1.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF00536; SAM_1; 1.
DR   PIRSF; PIRSF000666; TyrPK_ephrin_receptor; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00615; EPH_lbd; 1.
DR   SMART; SM01411; Ephrin_rec_like; 1.
DR   SMART; SM00060; FN3; 2.
DR   SMART; SM00454; SAM; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF47769; SSF47769; 1.
DR   SUPFAM; SSF49265; SSF49265; 1.
DR   SUPFAM; SSF49785; SSF49785; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS51550; EPH_LBD; 1.
DR   PROSITE; PS50853; FN3; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS00790; RECEPTOR_TYR_KIN_V_1; 1.
DR   PROSITE; PS00791; RECEPTOR_TYR_KIN_V_2; 1.
DR   PROSITE; PS50105; SAM_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cell membrane;
KW   Cell projection; Complete proteome; Glycoprotein; Kinase; Membrane;
KW   Neurogenesis; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Receptor; Reference proteome; Repeat; Signal; Transferase;
KW   Transmembrane; Transmembrane helix; Tyrosine-protein kinase.
FT   SIGNAL        1     24       {ECO:0000255}.
FT   CHAIN        25   1037       Ephrin type-A receptor 5.
FT                                /FTId=PRO_0000016812.
FT   TOPO_DOM     25    573       Extracellular. {ECO:0000255}.
FT   TRANSMEM    574    594       Helical. {ECO:0000255}.
FT   TOPO_DOM    595   1037       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       60    238       Eph LBD. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00883}.
FT   DOMAIN      357    467       Fibronectin type-III 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      468    562       Fibronectin type-III 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      675    936       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      965   1029       SAM. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00184}.
FT   NP_BIND     681    689       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOTIF      1035   1037       PDZ-binding. {ECO:0000255}.
FT   COMPBIAS    220    354       Cys-rich.
FT   ACT_SITE    800    800       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10028}.
FT   BINDING     707    707       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     650    650       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000250}.
FT   MOD_RES     656    656       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000250}.
FT   MOD_RES     833    833       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000255}.
FT   MOD_RES     982    982       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000250}.
FT   CARBOHYD    264    264       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    299    299       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    369    369       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    423    423       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    436    436       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    461    461       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1     69       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_039118.
FT   VAR_SEQ     563    563       F -> SV (in isoform 3).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_039119.
FT   VAR_SEQ     597    619       SCCECGCGRASSLCAVAHPSLIW -> R (in isoform
FT                                2). {ECO:0000305}.
FT                                /FTId=VSP_002999.
FT   VARIANT      81     81       N -> T (in dbSNP:rs33932471).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042138.
FT   VARIANT     235    235       S -> A (in dbSNP:rs55710198).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042139.
FT   VARIANT     330    330       E -> Q (in dbSNP:rs56205382).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042140.
FT   VARIANT     417    417       R -> Q (in a lung adenocarcinoma sample;
FT                                somatic mutation; dbSNP:rs199614818).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042141.
FT   VARIANT     503    503       E -> K (in a lung large cell carcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042142.
FT   VARIANT     506    506       Y -> C (in dbSNP:rs56074660).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_045912.
FT   VARIANT     582    582       G -> E (in a lung adenocarcinoma sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042143.
FT   VARIANT     672    672       A -> T (in dbSNP:rs36050417).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042144.
FT   VARIANT     673    673       S -> T (in dbSNP:rs56359290).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042145.
FT   VARIANT     856    856       T -> I (in a lung squamous cell carcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042146.
FT   VARIANT     959    959       H -> R (in dbSNP:rs56312931).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042147.
FT   VARIANT    1032   1032       N -> S (in a lung large cell carcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042148.
FT   CONFLICT     11     11       R -> H (in Ref. 1; CAA64700).
FT                                {ECO:0000305}.
FT   CONFLICT     87     87       G -> D (in Ref. 3; CAD97914).
FT                                {ECO:0000305}.
FT   CONFLICT    506    506       Y -> H (in Ref. 1; CAA64700).
FT                                {ECO:0000305}.
FT   CONFLICT    611    611       A -> V (in Ref. 3; CAD97914).
FT                                {ECO:0000305}.
FT   CONFLICT    616    616       S -> I (in Ref. 1; CAA64700).
FT                                {ECO:0000305}.
FT   CONFLICT    820    820       G -> E (in Ref. 3; CAD97914).
FT                                {ECO:0000305}.
FT   STRAND       61     65       {ECO:0000244|PDB:4ET7}.
FT   TURN         66     68       {ECO:0000244|PDB:4ET7}.
FT   STRAND       76     89       {ECO:0000244|PDB:4ET7}.
FT   STRAND       95    101       {ECO:0000244|PDB:4ET7}.
FT   STRAND      105    107       {ECO:0000244|PDB:4ET7}.
FT   STRAND      111    114       {ECO:0000244|PDB:4ET7}.
FT   STRAND      126    135       {ECO:0000244|PDB:4ET7}.
FT   HELIX       137    139       {ECO:0000244|PDB:4ET7}.
FT   STRAND      148    157       {ECO:0000244|PDB:4ET7}.
FT   HELIX       166    168       {ECO:0000244|PDB:4ET7}.
FT   STRAND      172    178       {ECO:0000244|PDB:4ET7}.
FT   STRAND      188    192       {ECO:0000244|PDB:4ET7}.
FT   STRAND      196    202       {ECO:0000244|PDB:4ET7}.
FT   STRAND      207    219       {ECO:0000244|PDB:4ET7}.
FT   STRAND      221    230       {ECO:0000244|PDB:4ET7}.
FT   HELIX       663    665       {ECO:0000244|PDB:2R2P}.
FT   HELIX       672    674       {ECO:0000244|PDB:2R2P}.
FT   STRAND      675    683       {ECO:0000244|PDB:2R2P}.
FT   STRAND      685    694       {ECO:0000244|PDB:2R2P}.
FT   STRAND      702    708       {ECO:0000244|PDB:2R2P}.
FT   HELIX       715    728       {ECO:0000244|PDB:2R2P}.
FT   STRAND      739    743       {ECO:0000244|PDB:2R2P}.
FT   STRAND      745    748       {ECO:0000244|PDB:2R2P}.
FT   STRAND      750    754       {ECO:0000244|PDB:2R2P}.
FT   HELIX       761    766       {ECO:0000244|PDB:2R2P}.
FT   TURN        767    770       {ECO:0000244|PDB:2R2P}.
FT   HELIX       774    793       {ECO:0000244|PDB:2R2P}.
FT   HELIX       803    805       {ECO:0000244|PDB:2R2P}.
FT   STRAND      806    808       {ECO:0000244|PDB:2R2P}.
FT   STRAND      814    816       {ECO:0000244|PDB:2R2P}.
FT   HELIX       842    844       {ECO:0000244|PDB:2R2P}.
FT   HELIX       847    852       {ECO:0000244|PDB:2R2P}.
FT   HELIX       857    873       {ECO:0000244|PDB:2R2P}.
FT   TURN        878    881       {ECO:0000244|PDB:2R2P}.
FT   HELIX       884    893       {ECO:0000244|PDB:2R2P}.
FT   HELIX       905    914       {ECO:0000244|PDB:2R2P}.
FT   HELIX       919    921       {ECO:0000244|PDB:2R2P}.
FT   HELIX       925    936       {ECO:0000244|PDB:2R2P}.
SQ   SEQUENCE   1037 AA;  114803 MW;  578C2F4D950DE419 CRC64;
     MRGSGPRGAG RRRPPSGGGD TPITPASLAG CYSAPRRAPL WTCLLLCAAL RTLLASPSNE
     VNLLDSRTVM GDLGWIAFPK NGWEEIGEVD ENYAPIHTYQ VCKVMEQNQN NWLLTSWISN
     EGASRIFIEL KFTLRDCNSL PGGLGTCKET FNMYYFESDD QNGRNIKENQ YIKIDTIAAD
     ESFTELDLGD RVMKLNTEVR DVGPLSKKGF YLAFQDVGAC IALVSVRVYY KKCPSVVRHL
     AVFPDTITGA DSSQLLEVSG SCVNHSVTDE PPKMHCSAEG EWLVPIGKCM CKAGYEEKNG
     TCQVCRPGFF KASPHIQSCG KCPPHSYTHE EASTSCVCEK DYFRRESDPP TMACTRPPSA
     PRNAISNVNE TSVFLEWIPP ADTGGRKDVS YYIACKKCNS HAGVCEECGG HVRYLPRQSG
     LKNTSVMMVD LLAHTNYTFE IEAVNGVSDL SPGARQYVSV NVTTNQAAPS PVTNVKKGKI
     AKNSISLSWQ EPDRPNGIIL EYEIKYFEKD QETSYTIIKS KETTITAEGL KPASVYVFQI
     RARTAAGYGV FSRRFEFETT PVFAASSDQS QIPVIAVSVT VGVILLAVVI GVLLSGSCCE
     CGCGRASSLC AVAHPSLIWR CGYSKAKQDP EEEKMHFHNG HIKLPGVRTY IDPHTYEDPN
     QAVHEFAKEI EASCITIERV IGAGEFGEVC SGRLKLPGKR ELPVAIKTLK VGYTEKQRRD
     FLGEASIMGQ FDHPNIIHLE GVVTKSKPVM IVTEYMENGS LDTFLKKNDG QFTVIQLVGM
     LRGISAGMKY LSDMGYVHRD LAARNILINS NLVCKVSDFG LSRVLEDDPE AAYTTRGGKI
     PIRWTAPEAI AFRKFTSASD VWSYGIVMWE VVSYGERPYW EMTNQDVIKA VEEGYRLPSP
     MDCPAALYQL MLDCWQKERN SRPKFDEIVN MLDKLIRNPS SLKTLVNASC RVSNLLAEHS
     PLGSGAYRSV GEWLEAIKMG RYTEIFMENG YSSMDAVAQV TLEDLRRLGV TLVGHQKKIM
     NSLQEMKVQL VNGMVPL
//
